SPECTRUM PHARMACEUTICALS INC's ticker is SPPI and the CUSIP is 84763A108.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $76,300 | -41.9% | 35,000 | 0.0% | 0.00% | -50.0% |
| Q2 2021 | $131,250 | +15.0% | 35,000 | 0.0% | 0.01% | 0.0% |
| Q1 2021 | $114,100 | -4.4% | 35,000 | 0.0% | 0.01% | -14.3% |
| Q4 2020 | $119,350 | -16.4% | 35,000 | 0.0% | 0.01% | -30.0% |
| Q3 2020 | $142,800 | +20.7% | 35,000 | 0.0% | 0.01% | +11.1% |
| Q2 2020 | $118,300 | +45.1% | 35,000 | 0.0% | 0.01% | +12.5% |
| Q1 2020 | $81,550 | -36.0% | 35,000 | 0.0% | 0.01% | -27.3% |
| Q4 2019 | $127,400 | -56.1% | 35,000 | 0.0% | 0.01% | -62.1% |
| Q3 2019 | $290,325 | -3.7% | 35,000 | 0.0% | 0.03% | -3.3% |
| Q2 2019 | $301,350 | -19.5% | 35,000 | 0.0% | 0.03% | -26.8% |
| Q1 2019 | $374,150 | +22.2% | 35,000 | 0.0% | 0.04% | +2.5% |
| Q4 2018 | $306,250 | -47.9% | 35,000 | 0.0% | 0.04% | -38.5% |
| Q3 2018 | $588,000 | +12.2% | 35,000 | +40.0% | 0.06% | +4.8% |
| Q2 2018 | $524,000 | +62.8% | 25,000 | +25.0% | 0.06% | +59.0% |
| Q1 2018 | $321,800 | -19.9% | 20,000 | -5.7% | 0.04% | -20.4% |
| Q4 2017 | $401,740 | -30.7% | 21,200 | -48.5% | 0.05% | -35.5% |
| Q3 2017 | $579,684 | – | 41,200 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,177,115 | $1,495,000 | 1.27% |
| ARMISTICE CAPITAL, LLC | 9,665,756 | $12,276,000 | 0.20% |
| CM Management, LLC | 150,000 | $191,000 | 0.14% |
| FSB PREMIER WEALTH MANAGEMENT, INC. | 200,000 | $254,000 | 0.11% |
| Manteio Capital LLC | 57,586 | $73,000 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 410,691 | $522,000 | 0.07% |
| SYNTAX ADVISORS, LLC | 29,181 | $37,000 | 0.03% |
| CAXTON ASSOCIATES LP | 164,096 | $208,000 | 0.02% |
| Alpine Global Management, LLC | 97,650 | $124,000 | 0.02% |
| Sonora Investment Management Group, LLC | 82,000 | $104,000 | 0.01% |